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BACKGROUND: Assessment of the outflow tract views is an integral 
part of routine fetal cardiac scanning. For some congenital heart defects, 
notably coarctation of the aorta, pulmonary valve stenosis, and aortic 
valve stenosis, the size of vessels is important both for diagnosis and 
prognosis. Existing reference ranges of fetal outflow tracts are derived 
from a small number of cases.
METHODS AND RESULTS: The study population comprised 7945 fetuses 
at 13 to 36 weeks’ gestation with no detectable abnormalities from 
pregnancies resulting in normal live births. Prospective measurements 
were taken of (1) the aortic and pulmonary valves in diastole at the 
largest diameter with the valve closed, (2) the distal transverse aortic arch 
on the 3 vessel and trachea view beyond the trachea at the distal point 
at its widest systolic diameter, and (3) the arterial duct on the 3 vessel 
and trachea view at its widest systolic diameter. Regression analysis, with 
polynomial terms to assess for linear and nonlinear contributors, was used 
to establish the relationship between each measurement and gestational 
age. The measurement for each cardiac diameter was expressed as a 
z score (difference between observed and expected value divided by 
the fitted SD corrected for gestational age) and percentile. Analysis 
included calculation of gestation-specific SDs. Regression equations are 
provided for the cardiac outflow tracts and for the distal transverse aortic 
arch:arterial duct ratio.
CONCLUSIONS: The study established reference ranges for fetal outflow 
tract measurements at 13 to 36 weeks’ gestation that are useful in clinical 
practice.
© 2018 American Heart Association, Inc.
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During fetal life, congenital heart disease is typi-cally suspected either by obstetric ultrasound examination or specialist fetal echocardiography. 
Over recent years, the outflow tract views have been in-
tegrated into routine fetal screening.1,2 For many forms 
of congenital heart disease, the primary diagnosis is not 
based on the size of heart structures but by recognition 
of abnormal cardiac connections. However, for some 
cardiac lesions, notably coarctation of the aorta, pul-
monary valve stenosis, and aortic valve stenosis, the size 
of vessels is an important consideration both for diag-
nosis and prognosis.3–6 It can be extremely important 
to compare an observed size of a valve or vessel to a 
size expected at a particular gestational age (GA).7 One 
method of assessing potential deviation from normal-
ity is by the use of z scores which describe the num-
ber of gestation-specific SDs a given measurement lies 
from the gestation-specific mean.8 The impact of this 
method of assessment is well described in fetal cardiol-
ogy particularly with respect to prediction of postnatal 
development of coarctation of the aorta, early neonatal 
intervention in tetralogy of Fallot and of single versus 
biventricular repair in cases of critical left or right ven-
tricular outflow tract obstruction,5,6,9–15 and identifica-
tion of suitable cases for fetal cardiac intervention.16–18 
Reference ranges of fetal outflow tracts have been 
published previously, but the number of cases exam-
ined was small ranging from 130 to 390.19–21 Lee at al22 
published a series of 2735 cases, but measurements of 
the aortic and ductal arches were not reported.
The objective of this study is to report reference 
ranges for the diameter of fetal aortic valve, pulmonary 
valve, arterial duct, and distal transverse aortic arch 
(DTAA) and the ratio of DTAA: arterial duct from the 
study of 7945 fetuses who had measurements made 
prospectively at a single tertiary fetal cardiology center.
METHODS
The data, analytic methods, and study materials will not be 
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure but can be 
available on request. All fetal echocardiograms performed or 
reported by a fetal cardiologist between 2002 and 2015 were 
identified from the departmental database (Viewpoint version 
5.6, General Electric Healthcare) at Harris Birthright Center 
for Fetal Medicine at King’s College Hospital, London, United 
Kingdom. The center serves the local population and also 
receives tertiary referrals for fetal medicine, including fetal 
cardiology, predominantly from the South East of England. 
Fetal echocardiography is performed for a wide variety of 
predefined indications, including family history of congenital 
heart disease, elevated nuchal translucency, or suspected con-
genital heart disease. Measurement of the size of the aorta, 
pulmonary artery, ductal arch, and aortic arch was part of the 
cardiac protocol throughout the study period, and all mea-
surements were made prospectively. In all cases, pregnancy 
dating was based on an ultrasound measurement of the fetal 
crown-rump length at 11 to 13 weeks’ gestation. This was a 
cross-sectional study and measurements of the outflow tracts 
from each fetus were taken only once. Pregnancy outcome 
was obtained from the hospital records, general practitioners, 
or the parents.
Inclusion Criteria
The inclusion criteria were singleton pregnancies with fetal 
echocardiography at 13 to 36 weeks’ gestation, resulting in 
the live birth of phenotypically normal babies.
Exclusion Criteria
The exclusion criteria were GA <13 and >36 weeks’ gesta-
tion, prenatal, or postnatal diagnosis of any form of con-
genital heart disease or variant of normal cardiac anatomy 
(persistent left superior vena cava, aberrant right subclavian 
artery, interrupted inferior vena cava, left atrial isomerism, 
CLINICAL PERSPECTIVE
Before birth, congenital heart disease is typically 
suspected by recognition of abnormal cardiac 
anatomy during screening or specialist ultrasound 
examination. However, for lesions such as coarc-
tation of the aorta, pulmonary stenosis, or aortic 
stenosis, the size of the outflow tracts relative to 
that expected at a particular gestational age is an 
important consideration both for diagnosis and 
prognosis.
We report gestation-specific reference ranges and 
z scores for the cardiac outflow tracts from a phe-
notypically normal population of >7000 fetuses 
between 13 and 36 weeks’ gestation. The pulmo-
nary and aortic valves were measured in diastole 
at maximal diameter when closed thus enabling 
visualization of the valve. Previously, measurement 
of the aortic isthmus was described, but techni-
cally this structure is not identifiable on standard 
transverse views and thus, we describe the mea-
surement of the distal transverse aortic arch at 
its widest systolic diameter made on the 3 vessel 
and tracheal view beyond the trachea. Regression 
analysis, with polynomial terms to assess for lin-
ear and nonlinear contributors, was used to estab-
lish the relationship between each measurement 
and gestational age. Gestation-specific SDs were 
calculated.
We have established reference ranges for fetal 
outflow tract measurements which should prove 
useful in clinical practice. They may provide further 
insight into the natural history of valve lesions in 
fetal life and provide increased confidence of nor-
mal ranges in size across a wide gestational age 
range.
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malposition of the heart), major extracardiac defect, chromo-
somal abnormality, genetic syndrome, termination of preg-
nancy, and intrauterine or neonatal death.
Measurements
All fetal echocardiograms were reviewed contemporane-
ously by a fetal cardiologist and measurements were made 
prospectively at the time of the scan (Drs Vigneswaran, 
Zidere, Charakida and Professors Allan, Simpson). Our scan-
ning protocol uses a series of transverse views to assess the 
4 chamber view and outflow tracts consistent with pub-
lished recommendations.1 The left and right ventricular 
outflow tracts were assessed using this approach, and the 
aortic arch and ductal arch were assessed in the 3 vessel 
and tracheal view as shown in Figure 1. Measurements were 
made with the ultrasound beam orthogonal to the plane of 
the vessel where possible, but other projections were used 
if fetal lie was less favorable. Online measurements were 
made of the aortic valve, pulmonary valve, DTAA, and arte-
rial duct diameters using electronic calipers. Our policy was 
to measure the semilunar valves at their largest diameter in 
diastole with the valve closed so that the exact position of 
the valve was clear. Measurements were made from inner 
edge to inner edge on 2-dimensional (2D) echocardiogra-
phy. The aortic arch was measured at its most distal point 
beyond the trachea at the widest systolic diameter (DTAA). 
This region is often referred to as the aortic isthmus in fetal 
life, but as the relationship to the left subclavian artery and 
arterial duct cannot be determined on this view, we have 
referred to it as the DTAA. The arterial duct was measured 
on the same view at its widest systolic diameter (Figure 1). 
Measurements were made only where the relevant struc-
ture could be visualized adequately at the time of the scan 
so not all measurements could be made in every patient. 
Echocardiograms were performed using the Acuson Aspen 
Advanced (Acuson, Mountain View, CA) with a 4 to 7 MHz 
curvilinear probe or a Voluson E8 (GE Medical Systems, Zipf, 
Austria) with a 4 to 8 MHz or 6 MHz curvilinear probe appro-
priate to the GA.
Statistical Analysis
A reference range for fetal echocardiographic measurements 
was established from the study population of pregnancies 
with live births that fulfilled the inclusion criteria. The distribu-
tions for each fetal cardiac measurement were assessed for 
Gaussian normality by inspecting histograms and probability 
plots. Transformation of data were considered if the distribu-
tion of the variable was non-Gaussian. In case of each mea-
surement, the mean and SD of the normally distributed data 
were estimated. The study population for development of 
reference range was selected for each cardiac measurement 
by excluding outliers outside the mean±3 SD. The selected 
population after exclusion of outliers was reassessed to ensure 
Gaussian normality as described above. Regression analysis 
was used to examine the association of each cardiac measure-
ment with GA at measurement. Before the regression analy-
sis, the GA was centered by subtracting the arithmetic mean 
from the GA in weeks to minimize effects of multicollinearity 
Figure 1. Measurement of cardiac structures.  
A, Aortic valve is measured in diastole at the largest diameter with the valve closed. B, Pulmonary valve is measured in diastole at the largest diameter with the 
valve closed. C, Distal transverse aortic arch is measured on the 3 vessel and tracheal view beyond the trachea at the distal point at its widest systolic diameter. D, 
Arterial duct is measured on the 3 vessel and tracheal view at its widest systolic diameter. All measurements are made inner edge to inner edge.
 by guest on July 14, 2018
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
Circ Cardiovasc Imaging. 2018;11:e007575. DOI: 10.1161/CIRCIMAGING.118.007575 July 2018 4
Vigneswaran et al; Fetal Outflow Tract Z Scores
associated with introduction of polynomial terms in the regres-
sion analysis.23 The relationship between the dependent vari-
able for each cardiac measurement and the independent 
variable of GA was assessed for linear and nonlinear trends 
by introducing polynomial terms in the regression analysis to 
determine the best fit. The significance of contribution of vari-
ables was assessed by examination of P values and effect size. 
The effect size of the coefficients was assessed by calculating 
Cohen’s d (coefficient/SD) and partial η2 from the multivariate 
regression analysis. Effect size of Cohen’s d ≤0.2 and partial 
η2 ≤0.01 was considered small. The final model was selected 
based on the terms that provided a significant contribution 
in prediction of the cardiac measurement. To determine the 
parametric reference centiles, we estimated whether the SD 
was constant or was dependant on the GA at measurement 
by regression analysis of the residuals on estimated mean 
value of the cardiac measurement using linear and nonlinear 
terms. The fitted SD was then estimated by multiplying the 
expected absolute residuals derived from the regression analy-
sis by √π/2, where π=3.14159. The observed measurement 
for each cardiac measurement was then expressed as a z score 
(difference between observed and expected value divided by 
the fitted SD corrected for GA) and percentile. The reference 
range for each measurement were constructed using the fifth, 
10th, 50th, 90th, and 95th percentiles. The statistical software 
package SPSS 24.0 (IBM SPSS Statistics for Windows, Version 
24.0. Armonk, NY: IBM Corp, 2016) and Medcalc, version 15.0 
(Medcalc Software, Ostend, Belgium) were used for the data 
analyses. Institutional review board approval was not required 
as all data were collected for clinical purposes according to a 
defined clinical protocol and consent was not required.
RESULTS
During the study period 17 292 fetal echocardiograms 
were performed and 7945 of these fulfilled the inclu-
sion criteria. The indications for fetal echocardiogra-
phy are shown in Table 1. The ethnicity of the mother 
was recorded as: white (n=6139), Afro-Caribbean 
(n=1102), South Asian (n=343), East Asian (n=191), 
and mixed race (n=170). The number of cases ana-
lyzed for each variable were aortic valve: 7544, pulmo-
nary valve: 7535, arterial duct: 6176, DTAA: 6176, and 
DTAA: arterial duct ratio 6176. All variables showed 
Gaussian distribution (Figure  2) and therefore trans-
formation was not required. A polynomial regression 
equation using GA provided the best fit for all the 
data. Increasing the order beyond a squared analysis 
showed no significant improvement in the fit of the 
model for the aortic valve, pulmonary valve, DTAA, and 
arterial duct measures. The coefficients for the regres-
sion equations are provided in Table 2 and further data 
are available in Tables I through V in the Data Supple-
ment and Figure 3. The z score for each parameter can 
be calculated as follows:
Z score
Observed measurement
Expected measurement
fi− =
−




 
 
/ tted SD 
where Expected=Intercept+a(GA−20)+b(GA−20)2+c
(GA−20)3; 
SD=Intercept+d(expected value)+e(expected value)2; 
and fitted SD=1.253314×SD.
DISCUSSION
This study has established reference ranges for fetal 
outflow tract measurements from 13 to 36 weeks’ ges-
tation. The strengths of the study include first, examina-
tion of a large number of fetuses in all 3 trimesters of 
pregnancy; second, accurate pregnancy dating based on 
the measurement of fetal crown-rump length in the first 
trimester; and third, inclusion of fetuses with known nor-
mal outcome and exclusion of those with abnormalities 
which were only apparent after birth and furthermore, 
prospective recording of measurements according to a 
defined protocol under the supervision of a team of fetal 
cardiologists. In previous studies the number of fetuses 
examined was very small and in the case of z score for 
the aortic arch the number was <400;19–21 second, in one 
study pregnancy dating was based on menstrual age,22 
which can be inaccurate; and third, in some studies post-
natal outcome was not ascertained.19,22
The prospective approach used in our study avoided 
the potential selection bias of retrospective studies which 
can result in inclusion of only the best images. This 
approach, however, may carry its own confirmation bias 
because each study is performed by the individual opera-
tors for a known specific indication; the mindset of the 
operator might be different if he or she were simply per-
forming the measurements to collect data. In the devel-
opment of reference ranges there is a balance between 
accurate sampling with one observer using very strict 
methodology and of multiple observers that accounts for 
the variability in quantification among observers.
We included measurements from fetuses of diabetic 
mothers and those with an isolated increased nuchal 
translucency thickness, provided there were no cardiac 
Table 1. Indications for Fetal Echocardiography
Referral Reason No. of Cases
Increased nuchal translucency 4220
High risk for trisomies 19
Family history of congenital heart disease 705
Maternal diabetes mellitus 454
Maternal anti-Ro antibodies 40
Suspected congenital heart disease 1014
Maternal exposure to teratogenic drug 170
Advanced maternal age 44
Potential rhythm disturbance 90
Heart difficult to image 514
Tricuspid regurgitation at first-trimester scan 675
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or extracardiac defects, and the pregnancies resulted 
in live births with no abnormalities. We deliberately 
included such fetuses because they constitute a high 
proportion of referrals for specialist fetal echocardiog-
raphy and their exclusion may skew the reference rang-
es or make them nonapplicable. Previous studies have 
Figure 2. A–D, Histograms demonstrating Gaussian distribution for all variables.
Table 2. Coefficients for Calculation of Estimated Population Mean and SD
Parameter
Expected Mean SD
Intercept a b c Intercept d e
Aortic valve diameter 3.21642 0.23062 0.00612 … −0.07740 0.17950 −0.01889
Pulmonary valve diameter 3.62029 0.27517 0.00586 … 0.06882 0.06978 …
Arterial duct diameter 2.25683 0.15999 0.00485 … 0.08028 0.08233 …
DTAA diameter 2.57163 0.18126 0.00513 … 0.07811 0.06885 …
Ratio of DTAA: arterial duct 1.1583 0.0070 0.0015 −0.0001 −0.4876 0.5306 …
Where a, b, c, d, and e are multipliers. The estimated population mean is to be calculated as intercept+a(GA−20)+b(GA−20)2+ 
c(GA−20)3 and SD as intercept+d(estimated mean)+e(estimated mean)2. DTAA indicates distal transverse aortic arch.
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excluded fetuses of diabetic mothers21,22 and those with 
increased nuchal translucency thickness.20–22
From a technical perspective, the measurement of 
the arterial valves was made with the valve closed and 
therefore the valve was visible making the measure-
ment straightforward. This is in contrast to measure-
ment during systole where the valve is not visible, but 
the exact approach and preference will vary by institu-
tion. Measurement of the distal aortic arch was per-
formed on the 3 vessel and tracheal view and z scores 
are provided for this mode of measurement. Other 
studies have used sagittal measurements which have 
the advantage that the head and neck vessels may be 
visualized. However, sagittal views do not permit side 
by side comparison of the ductal and aortic arches and 
visualization is more dependent on the fetal lie than 
the 3 vessel and tracheal view which has been widely 
adopted during screening.1 Finally, we used a standard 
statistical methodology which was used to create fetal 
reference measurements and z scores which vary with 
gestation.23 To create accurate z scores and centiles 
we used linear and nonlinear trends in a large series 
of patients to derive not just the regressed means, but 
also to derive accurate estimates of variance by examin-
ing the relationship of residuals with GA using linear 
and polynomial trends.
Figure 3. A–D, Graphical display of reference ranges for each variable with a demonstration of 1st, 5th, 50th, 95th, and 99th centiles.  
The measurement of the aortic and pulmonary valves was made in diastole at the largest diameter with the valve closed. The distal transverse aortic arch was 
measured on the 3 vessel and tracheal view beyond the trachea at the distal point at its widest systolic diameter. The arterial duct was measured on the 3 vessel 
and tracheal view at its widest systolic diameter.
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The reference ranges for cardiac outflow tracts and 
z scores presented in this study can be applied in the 
assessment of patients with cardiac asymmetry, pulmo-
nary stenosis, right ventricular outflow tract obstruc-
tion, or aortic stenosis2,3,5,10,11,13,15,16,18,24–32; in these cases 
knowledge of the accurate z score can aid in predicting 
the need for neonatal intervention and to plan perinatal 
management. Z scores may also be useful in forecasting 
the natural history of valve stenosis and in designing 
clinical trials on the value of in utero valvuloplasty, where 
patients can be stratified according to z scores.5,10,33,34 
A separate issue is whether measurement of the out-
flow tracts should constitute part of routine screening 
for prenatal diagnosis of outflow tract abnormalities. 
Published guidelines on fetal echocardiography1,2,35 by 
several professional bodies recommend assessment of 
relative size of outflow tracts, but such assessment does 
not stipulate actual measurement. Our reference rang-
es could be used as part of future prospective studies 
that compare subjective versus objective measurements 
of size. Ideally, our z scores would need to be validated 
in an unselected population-based cohort before they 
are utilized within screening programs.
Limitations
The study population was not derived from routine 
screening in pregnancy but from fetuses examined in 
a fetal cardiology clinic. Although we excluded cases 
of fetal abnormalities and adverse pregnancy outcome, 
it is possible that the values obtained may not be truly 
representative of those in an unselected normal popu-
lation. A further limitation is that in most patients nor-
mality was determined from a clinical examination in 
the neonatal period and it is possible that some genetic 
syndromes or chromosomal abnormalities may have not 
been diagnosed at this stage. In terms of major cardiac 
defects, we are confident that these would not have 
been missed as all babies with such defects are referred 
to our regional pediatric cardiac surgical center and 
thus feedback to the fetal medicine unit is provided.
Conclusions
The study has established reference ranges for fetal 
cardiac arterial measurements at 13 to 36 weeks’ ges-
tation that would assist both fetal medicine specialists 
and fetal cardiologists in clinical practice. The z scores 
can be used to assist in confirming normality, identi-
fying deviation from normal dimensions, or providing 
prognostic information.
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SUPPLEMENTAL MATERIAL 
 
  
 2 
Parameter Expected mean Standard deviation 
 β (95% confidence interval) SE p  β (95% confidence interval) SE p 
Aortic valve Intercept 3.21642  (3.20681 to 3.22604) 0.00490 <0.0001 Intercept -0.07740 (-0.29354 to 0.13874) 0.11026 0.483 
(GA in weeks – 20) 0.23062 (0.22236 to 0.23887) 0.00421 <0.0001 (Estimated aortic valve diameter) 0.17950 (0.05793 to 0.30107) 0.06202 0.004 
(GA in weeks – 20)2 -0.00612  (-0.00729 to -0.00496) 0.00059 <0.0001 (Estimated aortic valve diameter)2 -0.01889 (-0.03614 to -0.00165) 0.00880 0.032 
Pulmonary valve Intercept 3.62029 (3.60992 to 3.63066) 0.00529 <0.0001 Intercept 0.06882 (0.00708 to 0.13057) 0.03150 0.028 
(GA in weeks – 20) 0.27517 (0.26612 to 0.28421) 0.00462 <0.0001 (Estimated pulmonary valve diameter) 0.06978 (0.05351 to 0.08605) 0.00830 <0.0001 
(GA in weeks – 20)2 -0.00586 (-0.00729 to -0.00444) 0.00073 <0.0001 - - - - 
Arterial duct Intercept 2.25683 (2.24684 to 2.26683) 0.00510 <0.0001 Intercept 0.08028 (0.01797 to 0.14260) 0.03179 0.011 
(GA in weeks – 20) 0.15999  (0.15050 to 0.16948) 0.00484 <0.0001 (Estimated arterial duct diameter) 0.08233 (0.05605 to 0.10861) 0.01341 <0.0001 
(GA in weeks – 20)2 -0.00485 (-0.00602 to -0.00369) 0.00059 <0.0001 - - - - 
DTAA Intercept 2.57163 (2.56230 to 2.58096) 0.00476 <0.0001 Intercept 0.07811 (0.01869 to 0.13753) 0.03031 0.009 
(GA in weeks – 20) 0.18126 (0.17281 to 0.18971) 0.00431 <0.0001 (Estimated DTAA diameter) 0.06885 (0.04682 to 0.09087) 0.01123 <0.0001 
(GA in weeks – 20)2 -0.00513 (-0.00624 to -0.00401) 0.00057 <0.0001 - - - - 
DTAA: arterial duct ratio Intercept 1.1583 (1.1533 to 1.1633) 0.0026 <0.0001 Intercept -0.4876 (-0.8976 to -0.0597)  0.2137 0.025 
(GA in weeks – 20) -0.0070 (-0.0115 to -0.0025) 0.0023 0.002 (Estimated DTAA: arterial duct ratio) 0.5306 (0.1683 to 0.8930) 0.1848 0.004 
(GA in weeks – 20)2 0.0015 (0.0005 to 0.0015) 0.0005 0.003 
- - - - 
(GA in weeks – 20)3 -0.0001 (-0.0001 to 1.9e-05) 3.2 e-05 0.010 - - - - 
 
Supplementary table 1: Regression analysis intercept and multipliers for calculation of the estimated mean and the SD with 95% confidence interval and 
statistical significance of associations. [abbreviations: DTAA – distal transverse aortic arch] 
 
  
 Supplementary table 2: Values for aortic valve diameter based on 1st, 5th, 10th, 50th, 90th, 95th and 99th 
centiles according to gestational age. [abbreviations: GA – gestational age] 
 
   Aortic valve diameter 
GA No. cases 1st centile 5th centile 10th centile 50th centile 90th centile 95th centile 99th centile 
13 21 0.940 1.046 1.103 1.302 1.502 1.558 1.665 
14 28 1.137 1.277 1.351 1.612 1.874 1.948 2.087 
15 25 1.337 1.505 1.595 1.910 2.226 2.316 2.483 
16 38 1.538 1.731 1.834 2.196 2.559 2.661 2.854 
17 21 1.739 1.953 2.067 2.469 2.872 2.986 3.200 
18 69 1.938 2.170 2.294 2.731 3.167 3.291 3.523 
19 764 2.135 2.382 2.514 2.980 3.445 3.577 3.824 
20 4989 2.329 2.589 2.727 3.216 3.706 3.844 4.104 
21 751 2.518 2.788 2.932 3.441 3.949 4.094 4.364 
22 452 2.702 2.981 3.129 3.653 4.177 4.326 4.604 
23 210 2.880 3.165 3.317 3.853 4.389 4.541 4.826 
24 62 3.051 3.341 3.496 4.041 4.586 4.741 5.031 
25 33 3.215 3.508 3.665 4.217 4.768 4.925 5.218 
26 20 3.370 3.666 3.823 4.380 4.936 5.094 5.390 
27 32 3.516 3.813 3.972 4.531 5.090 5.248 5.546 
28 64 3.653 3.951 4.109 4.670 5.230 5.389 5.687 
29 23 3.779 4.077 4.236 4.796 5.357 5.516 5.814 
30 11 3.895 4.192 4.351 4.911 5.470 5.629 5.927 
31 18 3.999 4.296 4.454 5.013 5.571 5.729 6.026 
32 22 4.092 4.388 4.546 5.103 5.659 5.817 6.113 
33 16 4.173 4.468 4.625 5.180 5.735 5.892 6.188 
34 17 4.242 4.536 4.692 5.246 5.799 5.955 6.250 
35 6 4.298 4.591 4.747 5.299 5.850 6.006 6.300 
36 10 4.341 4.634 4.790 5.340 5.890 6.046 6.338 
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Supplementary table 3: Values for pulmonary valve diameter based on 1st, 5th, 10th, 50th, 90th, 95th and 
99th centiles according to gestational age. [abbreviations: GA – gestational age] 
 
   Pulmonary valve diameter 
GA No. cases 1st centile 5th centile 10th centile 50th centile 90th centile 95th centile 99th centile 
13 23 0.920 1.063 1.139 1.407 1.675 1.751 1.894 
14 25 1.200 1.363 1.451 1.758 2.066 2.153 2.317 
15 23 1.470 1.654 1.752 2.098 2.444 2.542 2.725 
16 38 1.732 1.935 2.043 2.426 2.808 2.917 3.120 
17 22 1.984 2.206 2.324 2.742 3.160 3.278 3.501 
18 71 2.226 2.466 2.595 3.047 3.499 3.627 3.867 
19 764 2.459 2.717 2.854 3.339 3.824 3.961 4.219 
20 4995 2.683 2.958 3.104 3.620 4.137 4.283 4.557 
21 753 2.898 3.188 3.343 3.890 4.436 4.591 4.882 
22 455 3.103 3.409 3.572 4.147 4.723 4.886 5.192 
23 209 3.299 3.619 3.790 4.393 4.996 5.167 5.487 
24 63 3.485 3.820 3.998 4.627 5.256 5.435 5.769 
25 33 3.662 4.010 4.196 4.850 5.504 5.689 6.037 
26 20 3.830 4.191 4.383 5.060 5.738 5.930 6.290 
27 34 3.989 4.361 4.559 5.259 5.959 6.158 6.530 
28 65 4.138 4.521 4.726 5.447 6.168 6.372 6.755 
29 24 4.278 4.672 4.881 5.622 6.363 6.573 6.967 
30 11 4.408 4.812 5.027 5.786 6.545 6.760 7.164 
31 18 4.529 4.942 5.162 5.938 6.714 6.934 7.347 
32 22 4.641 5.062 5.287 6.078 6.870 7.095 7.516 
33 14 4.744 5.172 5.401 6.207 7.013 7.242 7.671 
34 16 4.837 5.273 5.505 6.324 7.143 7.376 7.811 
35 6 4.921 5.363 5.598 6.429 7.260 7.496 7.938 
36 9 4.995 5.443 5.681 6.523 7.364 7.603 8.051 
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Supplementary table 4: Values for arterial duct diameter based on 1st, 5th, 10th, 50th, 90th, 95th and 99th 
centiles according to gestational age. [abbreviations: GA – gestational age] 
 
   Arterial Duct diameter 
GA No. cases 1st centile 5th centile 10th centile 50th centile 90th centile 95th centile 99th centile 
13 5 0.449 0.581 0.651 0.899 1.147 1.217 1.349 
14 5 0.619 0.766 0.845 1.122 1.400 1.478 1.626 
15 11 0.781 0.943 1.030 1.336 1.641 1.728 1.890 
16 27 0.936 1.112 1.207 1.539 1.872 1.966 2.143 
17 15 1.083 1.274 1.375 1.733 2.091 2.193 2.383 
18 51 1.223 1.426 1.535 1.917 2.300 2.408 2.612 
19 575 1.356 1.571 1.686 2.092 2.498 2.613 2.828 
20 4039 1.481 1.708 1.829 2.257 2.684 2.805 3.033 
21 637 1.599 1.837 1.964 2.412 2.860 2.987 3.225 
22 433 1.709 1.958 2.090 2.557 3.025 3.157 3.405 
23 201 1.813 2.071 2.208 2.693 3.178 3.316 3.574 
24 53 1.908 2.175 2.317 2.819 3.321 3.463 3.730 
25 29 1.997 2.272 2.418 2.936 3.453 3.599 3.874 
26 18 2.078 2.360 2.511 3.042 3.573 3.724 4.006 
27 30 2.152 2.441 2.595 3.139 3.683 3.837 4.127 
28 58 2.218 2.513 2.671 3.226 3.782 3.939 4.235 
29 22 2.277 2.578 2.738 3.304 3.870 4.030 4.331 
30 11 2.328 2.634 2.797 3.372 3.947 4.110 4.415 
31 17 2.372 2.682 2.847 3.430 4.012 4.178 4.487 
32 20 2.409 2.722 2.889 3.478 4.067 4.234 4.547 
33 14 2.439 2.755 2.923 3.517 4.111 4.280 4.595 
34 15 2.461 2.779 2.948 3.546 4.144 4.313 4.631 
35 5 2.476 2.795 2.965 3.565 4.166 4.336 4.655 
36 10 2.483 2.803 2.973 3.575 4.177 4.347 4.667 
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Supplementary table 5: Values for distal transverse aortic arch diameter based on 1st, 5th, 10th, 50th, 
90th, 95th and 99th centiles according to gestational age. [abbreviations: GA – gestational age] 
 
 
GA 
 
No. cases 
Distal transverse aortic arch diameter 
1st centile 5th centile 10th centile 50th centile 90th centile 95th centile 99th centile 
13 6 0.613 0.741 0.810 1.052 1.293 1.362 1.490 
14 11 0.811 0.954 1.030 1.300 1.569 1.645 1.788 
15 12 1.001 1.158 1.242 1.537 1.833 1.916 2.073 
16 26 1.183 1.353 1.444 1.765 2.085 2.176 2.346 
17 15 1.356 1.539 1.637 1.982 2.326 2.424 2.607 
18 52 1.522 1.717 1.821 2.189 2.556 2.660 2.856 
19 600 1.679 1.886 1.996 2.385 2.774 2.885 3.092 
20 4083 1.828 2.046 2.162 2.572 2.981 3.098 3.316 
21 643 1.968 2.197 2.318 2.748 3.177 3.299 3.527 
22 436 2.101 2.339 2.466 2.914 3.361 3.488 3.726 
23 206 2.225 2.473 2.604 3.069 3.534 3.666 3.913 
24 54 2.342 2.597 2.734 3.215 3.696 3.832 4.088 
25 31 2.450 2.713 2.854 3.350 3.846 3.986 4.250 
26 21 2.549 2.820 2.965 3.475 3.984 4.129 4.400 
27 30 2.641 2.919 3.067 3.589 4.112 4.260 4.537 
28 61 2.724 3.008 3.160 3.694 4.227 4.379 4.663 
29 22 2.800 3.089 3.243 3.788 4.332 4.486 4.776 
30 11 2.867 3.161 3.318 3.872 4.425 4.582 4.876 
31 18 2.925 3.224 3.383 3.945 4.507 4.666 4.965 
32 21 2.976 3.278 3.440 4.008 4.577 4.738 5.041 
33 16 3.019 3.324 3.487 4.062 4.636 4.799 5.105 
34 15 3.053 3.361 3.525 4.104 4.684 4.848 5.156 
35 6 3.079 3.389 3.554 4.137 4.720 4.885 5.195 
36 10 3.097 3.408 3.574 4.159 4.745 4.911 5.222 
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Supplementary table 6:  Assessment of significant of contribution of ethnicity in multivariate regression analysis by examination of significance value, 
Cohen’s D and partial η2 
 
 
 
 
 
 
* Cohen’s d (coefficient/SD) estimated for the Afro-Caribbean group as this was the only group with a significant p value 
 
 
 
 
 
Cardiac measurement P value Cohen’s D Partial η2 
Aortic valve diameter <0.001 -0.17* 0.005 
Pulmonary valve diameter <0.001 -0.14* 0.003 
Arterial duct diameter 0.410 0.048 0.0002 
DTAA diameter <0.001 0.12 0.003 
